Viewing Study NCT00954005

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-06-14 @ 4:20 PM
Study NCT ID: NCT00954005
Status: TERMINATED
Last Update Posted: 2015-08-19
First Post: 2009-08-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma
Sponsor: German Low Grade Lymphoma Study Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Indolent Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsed indolent lymphoma View
None gemcitabine View
None oxaliplatin View
None rituximab View